Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 245 member A (FAM245A), also known as LINC00864, is a long intergenic non-coding RNA (lincRNA) gene in humans[1][3]. lincRNAs are autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[4]. FAM245A does not encode a protein but may contribute to the regulation of chromatin state, genome architecture, and gene expression, often with tissue-specific effects typical of lincRNAs[4]. Some aliases (e.g., “cathepsin L-like 1 (pseudogene)”) arose from older annotations labeling it as a pseudogene, but there is no evidence it encodes a functional protein or acts as a traditional therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1][3]. No direct disease association, drug interaction, biomarker, or major therapeutic relevance is established for FAM245A based on current sources.
Not applicable, as no direct drug interactions are documented
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 245 member A (FAM245A).